Skip to main content
SpringerLink
Log in
Book cover

Mohs Micrographic Surgery pp 177–188Cite as

Basal Cell Carcinoma

  • Chapter
  • First Online:

Abstract

BCC is the most common neoplasm encountered in humans. It is also the most common indication for Mohs micrographic surgery (MMS). MMS has a 99% 5-year cure rate for primary BCCs. For recurrent BCCs, the 5-year cure rate is 96%. Infiltrating, micronodular, and morpheaform subtypes are considered more aggressive forms of BCC, and MMS should be the primary treatment for those subtypes. Inflammatory cells, hair follicles, and folliculocentric basaloid proliferations are benign conditions that can resemble BCC when using horizontal frozen sections. Malignant processes such as metastatic breast cancer, ameloblastoma, cloacogenic carcinoma, eccrine spiradenoma, pilomatricomas, and trichoepitheliomas can also mimic BCC. Additionally, BCC may differentiate to simulate many structures such as hair follicles, sweat glands, and sebaceous glands. The evidence behind MMS for BCC is strong with studies backed by a high number of patients along with very low recurrence rates. It is especially well suited for aggressive histological subtypes of BCC and for BCCs in anatomical regions where tissue conservation is paramount.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Neville JA, Welch E, Leffell DJ. Management of nonmelanoma skin cancer in 2007. Nat Clin Pract Oncol. 2007;4(8):462–9.

    Article  PubMed  Google Scholar 

  2. Welch ML, Anderson LL, Grabski WJ. How many nonmelanoma skin cancers require Mohs’ micrographic surgery? J Dermatol Surg. 1996;22:711–3.

    Article  CAS  Google Scholar 

  3. ACS. Cancer Facts & Figures 2001. http://www.cancer.org/downloads/STT/F&F2001.pdf (2001). Accessed March 19, 2002.

  4. Iwasaki JK, Srivastva D, Moy RL, Lin HJ, Kouba DJ. The molecular genetics underlying basal cell carcinoma pathogenesis and links to targeted therapeutics. J Am Acad Dermatol. Epub Aug 25, 2010.

    Google Scholar 

  5. Lear JT, Schmith AG. Basal cell carcinoma. Postgrad Med. 1997;73:538–42.

    Article  CAS  Google Scholar 

  6. Roewer-Huber J, Lange-Asschenfeldt B, Stockfleth E, Kerl H. Epidemiology and aetiology of basal cell carcinoma. Br J Dermatol. 2007;157 Suppl 2:47–51.

    Article  Google Scholar 

  7. Shriner D, McCoy DK, Goldberg DJ, WagnerJr R. Mohs micrographic surgery. J Am Acad Dermatol. 1998;39:79–97.

    Article  PubMed  CAS  Google Scholar 

  8. Tulli A. Mohs micrographic surgery. In: Chu T, Chu AC, Edelson RL, editors. Malignant tumors of the skin. London: England; 1999. p. 381–95.

    Google Scholar 

  9. Martinez JC, Otley CC. The management of melanoma and nonmelanoma skin cancer: a review for the primary care physician. Mayo Clin Proc. 2001;76:1253–65.

    Article  PubMed  CAS  Google Scholar 

  10. Xie J, Murone M, Luoh SM, et al. Activating smoothened mutations in sporadic basal-cell carcinoma. Nature. 1998;391:90–2.

    Article  PubMed  CAS  Google Scholar 

  11. Zedan W, Robinson PA, Markham AF, High AS. Expression of the Sonic Hedgehog receptor “PATCHED” in basal cell carcinomas and odontogenic keratocytes. J Pathol. 2001;194:473–7.

    Article  PubMed  CAS  Google Scholar 

  12. Rubin AI, Chen EH, Ratner D. Basal-cell carcinoma. N Engl J Med. 2005;353:2262–9.

    Article  PubMed  CAS  Google Scholar 

  13. Hahn H, Wojnowski L, Miller G, Zimmer A. The patched signalling pathway in tumorigenesis and development; lessons from animal models. J Mol Med. 1999;77:459–68.

    Article  PubMed  CAS  Google Scholar 

  14. Bonifas JM, Bare JW, Kerschmann RL, Maser SP, Epstein Jr EH. Paternal origin of chromosome 9q22.3-q31 lost in basal cell carcinomas from basal cell nevus Syndrome patients. Hum Mol Genet. 1994;3:447–8.

    Article  PubMed  CAS  Google Scholar 

  15. Donovan J. Review of the hair follicle origin hypothesis for basal cell carcinoma. Dermatol Surg. 2009;35:1311–23.

    Article  PubMed  CAS  Google Scholar 

  16. Kirkham N. Tumors and cysts of the epidermis. In: Elder DE, Elenitsas R, Johnson BL, Murphy GF, Xiaowei X, editors. Lever’s histopathology of the skin. 10th ed. Philadelphia: Lippincott Williams & Wilkins; 2008. p. 1048.

    Google Scholar 

  17. Okun MR, Blumental G. Basal cell epithelioma with giant cells and nuclear atypicality. Arch Dermatol. 1964;89:598.

    Article  PubMed  CAS  Google Scholar 

  18. Rupec M, Vakilzadeh F, Korb G. Über das vorkommen von mehrkernigen riesenzellen in basaliomen. Arch Klin Exp Dermatol. 1969;235:198.

    Article  PubMed  CAS  Google Scholar 

  19. Salasche SJ, Amonette R. Morpheaform basal-cell epitheliomas: a study of subclinical extensions in a series of 51 cases. J Dermatol Surg Oncol. 1981;7:387–93.

    PubMed  CAS  Google Scholar 

  20. Aoyagi S, Nouri K. Difference between pigmented and nonpigmented basal cell carcinoma treated with Mohs micrographic surgery. Dermatol Surg. 2006;32:1375–9.

    Article  PubMed  CAS  Google Scholar 

  21. Terashi H. Perineural and neural involvement in skin cancers. Dermatol Surg. 1997;22:259.

    Article  Google Scholar 

  22. Lang PG, Maize JC. Histologic evolution of recurrent basal cell carcinoma and treatment implications. J Am Acad Dermatol. 1986;14:186.

    Article  PubMed  Google Scholar 

  23. Leshin B, White WL. Folliculocentric basaloid proliferation. The bulge (der Wulst) revisited. Arch Dermatol. 1990;126(7):900–6.

    Article  PubMed  CAS  Google Scholar 

  24. Krunic AL, Garrod DR, Viehman GE, Madani S, Buchanan MD, Clark RE. The use of antidesmoglein stains in Mohs micrographic surgery. Dermatol Surg. 1997;23(6):463–8.

    Article  PubMed  CAS  Google Scholar 

  25. Garcia C, Poletti E, Crowson AN. Basosquamous carcinoma. J Am Acad Dermatol. 2009;60:137–43.

    Article  PubMed  Google Scholar 

  26. Borel DM. Cutaneous basosquamous carcinoma: review of the literature and report of 35 cases. Arch Pathol. 1973;95:293–7.

    PubMed  CAS  Google Scholar 

  27. Crowson AN. Basal cell carcinoma: biology, morphology and clinical implications. Mod Pathol. 2006;19(Suppl):S127–47.

    Article  PubMed  Google Scholar 

  28. de Lopes FJ, Nunes PH. Basosquamous cell carcinoma of the skin with metastases. Histopathology. 1988;12:85–94.

    Article  Google Scholar 

  29. Martin RC, Edwards MJ, Cawte TG, Sewell CL, McMasters KM. Basosquamous carcinoma: analysis of prognostic factors influencing recurrence. Cancer. 2000;88:1365–9.

    Article  PubMed  Google Scholar 

  30. Jones MS, Helm KF, Maloney ME. The immunohistochemical characteristics of the basosquamous cell carcinoma. Dermatol Surg. 1997;23:181–4.

    Article  PubMed  CAS  Google Scholar 

  31. Maloney ML. What is basosquamous carcinoma? Dermatol Surg. 2000;26:505–6.

    Article  PubMed  CAS  Google Scholar 

  32. Barksdale SK, O’Connor N, Barnhill R. Prognostic factors for cutaneous squamous cell and basal cell carcinoma: determinants of risk of recurrence, metastasis, and development of subsequent skin cancers. Surg Oncol Clin N Am. 1997;6:625–38.

    PubMed  CAS  Google Scholar 

  33. Randle HW. Basal cell carcinoma: identification and treatment of the high-risk patient. Dermatol Surg. 1996;22:255–61.

    Article  PubMed  CAS  Google Scholar 

  34. Leibovitch I, Huilgol SC, Selva D, Richards S, Paver R. Basosquamous carcinoma: treatment with Mohs micrographic surgery. Cancer. 2005;104:170–5.

    Article  PubMed  Google Scholar 

  35. Farmer ER, Helwig EB. Metastatic basal cell carcinoma: a clinicopathologic study of seventeen cases. Cancer. 1980;46:748–57.

    Article  PubMed  CAS  Google Scholar 

  36. VonDomarus H, Stevens PJ. Metastatic basal cell carcinoma: report of five cases and review of 170 cases in the literature. J Am Acad Dermatol. 1984;10:1043–60.

    Article  CAS  Google Scholar 

  37. Tavin E, Persky MS, Jacobs J. Metastatic basal cell carcinoma of the head and neck. Laryngoscope. 1995;105:814–7.

    Article  PubMed  CAS  Google Scholar 

  38. Schuller D, Berg JW, Sherman G, Krause CJ. Cutaneous basosquamous carcinoma of the head and neck: a comparative analysis. Otolaryngol Head Neck Surg. 1979;87(4):420–7.

    PubMed  CAS  Google Scholar 

  39. Schon MP, Schon M. Imiquimod: mode of action. Br J Dermatol. 2007;157(S2):8–13.

    Article  PubMed  Google Scholar 

  40. Goette DK. Topical chemotherapy with 5-fluorouracil. J Am Acad Dermatol. 1981;6:633–49.

    Article  Google Scholar 

  41. Acarturk TO, Edington H. Nonmelanoma skin cancer. Clin Plast Surg. 2005;32:237–48.

    Article  PubMed  Google Scholar 

  42. Cancer M-AGI. Toxicity of fluorouracil in patients with advanced colorectal cancer: effect of administration schedule and prognostic factors. J Clin Oncol. 1998;16(11):3537–41.

    Google Scholar 

  43. Serdar AM, Sertoğlu E, Uyanik M, Tapan S, Akin O, Cihan M. Determination of 5-fluorouracil and dihydrofluorouracil levels using a liquid chromatography-tandem mass spectrometry method for evaluation of dihydropyrimidine dehydrogenase enzyme activity. Cancer Chemother Pharmacol. 2011;68:525–9. Epub 24 Nov 2010.

    Article  PubMed  CAS  Google Scholar 

  44. Silverman MK, Kopf AW, Gladstein AH, Bart RS, Grin CM, Levenstein MJ. Recurrence rates of treated basal cell carcinomas. Part 4: X-ray therapy. J Dermatol Surg Oncol. 1992;18(7):549–54.

    PubMed  CAS  Google Scholar 

  45. Kuijpers DI, Thissen MR, Berretty PJ, Ideler FH, Nelemans PJ, Neumann MH. Surgical excision plus cryosurgery in the treament of basal cell carcinoma. Dermatol Surg. 2007;33:579–87.

    Article  PubMed  CAS  Google Scholar 

  46. Kokoszka A, Scheinfeld N. Evidence-based review of the use of cryosurgery in treatment of basal cell carcinoma. Dermatol Surg. 2003;29:566–71.

    PubMed  Google Scholar 

  47. Mallon E, Dawber R. Cryosurgery in the treatment of basal cell carcinoma. Assessment of one and two freeze-thaw schedules. Dermatol Surg. 1996;22:854–8.

    Article  PubMed  CAS  Google Scholar 

  48. Thissen MR, Nieman FH, Ideler AH, Berretty PJ, Neumann HA. Cosmetic results of cryosurgery versus surgical excision for primary uncomplicated basal cell carcinomas of the head and neck. Dermatol Surg. 2000;26:759–64.

    Article  PubMed  CAS  Google Scholar 

  49. Wang I, Bendsoe N, Klinteberg CA, et al. Photodynamic therapy vs. cryosurgery of basal cell carcinomas: results of a phase III clinical trial. Br J Dermatol. 2001;144(4):832–40.

    Article  PubMed  CAS  Google Scholar 

  50. Hall VL, Leppard BJ, McGill J, Kesseler ME, White JE, Goodwin P. Treatment of basal-cell carcinoma: comparison of radiotherapy and cryotherapy. Clin Radiol. 1986;37(1):33–4.

    Article  PubMed  CAS  Google Scholar 

  51. Werlinger KD, Upton G, Moore AY. Recurrence rates of primary nonmelanoma skin cancers treated by surgical excision compared to electrodesiccation-currettage in a private dermatological practice. Dermatol Surg. 2002;28:1138–42.

    Article  PubMed  Google Scholar 

  52. Germann G, Bernstein-Sommer B, Petrovici V, Steinau HU. Differential, oncologically adequate therapy of basalioma. Handchir Mikrochir Plast Chir. 1992;24(3):151–8.

    PubMed  CAS  Google Scholar 

  53. Bauer M, Loosli RM, Anderl J, Wilflingseder P. Surgical treatment of malignant skin epitheliomas. Principles, methods, results. Chirurg. 1977;48(3):170–9.

    PubMed  CAS  Google Scholar 

  54. Silverman MK, Kopf AW, Bart RS, Grin CM, Levenstein MS. Recurrence rates of treated basal cell carcinomas. Part 3: surgical excision. J Dermatol Surg Oncol. 1992;18(6):471–6.

    PubMed  CAS  Google Scholar 

  55. Bogdanov-Berezovsky A, Cohen AD, Glesinger R, Cagano E, Krieger Y, Rosenberg L. Risk factors for incomplete excision of basal cell carcinomas. Acta Derm Venereol. 2004;84(1):44–7.

    Article  PubMed  Google Scholar 

  56. LangJr PG, Osguthorpe JD. Indications and limitations of Mohs micrographic surgery. Dermatol Clin. 1989;7: 627–44.

    CAS  Google Scholar 

  57. Mohs FE. Chemosurgery. Microscopically controlled surgery for skin cancer. Springfield: Charles C Thomas; 1978. p. 153.

    Google Scholar 

  58. Robins P. Chemosurgery: my 15 years experience. J Dermatol Surg Oncol. 1981;7:779–89.

    PubMed  CAS  Google Scholar 

  59. Mohs FE. Micrographic surgery for the microscopically controlled excision of eyelid cancer. Arch Ophthalmol. 1986;104:901–9.

    Article  PubMed  CAS  Google Scholar 

  60. Robins P, Rodriquez-Sains R, Rabinovitz H, Rigel D. Mohs surgery for periocular basal cell carcinomas. J Dermatol Surg Oncol. 1985;11:1203–7.

    PubMed  CAS  Google Scholar 

  61. Bumsted RM, Ceilley RI, Panje WR, Curmley RL. Auricular malignant neoplasms. When is chemotherapy (Mohs’ technique) necessary? Arch Otolaryngol. 1981;107:721–4.

    Article  PubMed  CAS  Google Scholar 

  62. Downes RN, Waker NPJ, Collin JRO. Micrographic (Mohs) surgery in the management of periocular basal cell epitheliomas. Eye. 1990;4:160–8.

    Article  PubMed  Google Scholar 

  63. Swanson NA. Mohs Surgery. Technique, indications, applications and the future. Arch Dermatol. 1983;119:761–73.

    Article  PubMed  CAS  Google Scholar 

  64. Cottell WI, Proper S. Mohs’ surgery, fresh tissue technique. J Dermatol Surg Oncol. 1982;8:576–87.

    Google Scholar 

  65. Rappini RP. On the definition of Mohs surgery and how it determines appropriate surgical margins. Arch Dermatol. 1992;128:673–8.

    Article  Google Scholar 

  66. Wennberg AM, Larko O, Stenquist B. Five-year results of Mohs’ micrographic surgery for aggressive facial basal cell carcinoma in Sweden. Acta Derm Venereol. 1999;79:370–2.

    Article  PubMed  CAS  Google Scholar 

  67. Mosterd K, Krekels GAM, Nieman FHM, et al. Surgical excision versus Mohs’ micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomised controlled trial with 5-years’ follow-up. Lancet Oncol. 2008;9(12):1149–56.

    Article  PubMed  Google Scholar 

  68. Smeets NWJ, Krekels GAM, Ostertag JU, et al. Surgical excision vs Mohs’ micrographic surgery for basal-cell carcinoma of the face: randomised controlled trial. Lancet. 2004;364:1766–72.

    Article  PubMed  Google Scholar 

  69. Bennett RG. Current concepts in Mohs micrographic surgery. Dermatol Clin. 1991;9:777–88.

    PubMed  CAS  Google Scholar 

  70. Mehregan AH. Aggressive basal cell epithelioma on sunlight-protected skin: report of eight cases, one with pulmonary and bone metastases. Am J Dermatopathol. 1983;5:221–9.

    Article  PubMed  CAS  Google Scholar 

  71. Sloane JP. The value of typing basal cell carcinomas in predicting recurrence after surgical excision. Br J Dermatol. 1977;96:127–32.

    Article  PubMed  CAS  Google Scholar 

  72. Jacobs GH, Rippey JJ, Altinbi M. Prediction of aggressive behavior in basal cell carcinoma. Cancer. 1982;49:533–7.

    Article  PubMed  CAS  Google Scholar 

  73. Thackray AC. Histological classification of rodent ulcers and its bearing on their prognosis. Br J Cancer. 1951;5:213–24.

    Article  PubMed  CAS  Google Scholar 

  74. Dellon AL. Histologic study of recurrent basal cell carcinoma. Plast Reconstr Surg. 1985;75:853–9.

    Article  PubMed  CAS  Google Scholar 

  75. Siegle RJ, MacMillan J, Pollack SV. Infiltrative basal cell carcinoma: a nonsclerosing subtype. J Dermatol Surg Oncol. 1986;12:830–6.

    PubMed  CAS  Google Scholar 

  76. Hendrix JD, Parlette JL. Micronodular basal cell carcinoma: a deceptive histologic subtype with frequently clinically undetected tumor extension. Arch Dermatol. 1996;132:295–8.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology and Cutaneous Surgery, University of Miami Leonard M. Miller School of Medicine, Miami, FL, USA

    Michael P. McLeod, Sonal Choudhary & Keyvan Nouri

  2. Department of Dermatology and Cutaneous Surgery, University of Miami Hospital, Miami, FL, USA

    Yasser A. Alqubaisy

  3. Sylvester Comprehensive Cancer Center, University of Miami Hospital and Clinics, Miami, FL, USA

    Keyvan Nouri

Authors
  1. Michael P. McLeod
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sonal Choudhary
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yasser A. Alqubaisy
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Keyvan Nouri
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Keyvan Nouri .

Editor information

Editors and Affiliations

  1. Miller School of Medicine, Dept. Dermatology, University of Miami, NW. 10th Ave. 1600, Miami, 33136, Florida, USA

    Keyvan Nouri

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag London Limited

About this chapter

Cite this chapter

McLeod, M.P., Choudhary, S., Alqubaisy, Y.A., Nouri, K. (2012). Basal Cell Carcinoma. In: Nouri, K. (eds) Mohs Micrographic Surgery. Springer, London. https://doi.org/10.1007/978-1-4471-2152-7_16

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-2152-7_16

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-2151-0

  • Online ISBN: 978-1-4471-2152-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation